BioSapien Inc.
PrivateLast Round
VC Round
Jul 7, 2025
Total Funding Raised
$14.81M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BioSapien Inc. operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a VC Round in July 2025.
BioSapien Inc. is a biotechnology company that develops 3D-printed, biodegradable mesh chips designed to deliver pharmaceuticals directly to tumor sites.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, 3D Printing, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioSapien Inc. Comparables
Compare BioSapien Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PanTher Therapeutics | 89% | |
| RenovoRx | 75% | |
| NanOlogy, LLC | 74% |
For institutional investors. Book with your work email.
BioSapien Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 7, 2025 | ||||
| Early Funding | Jan 27, 2025 | ||||
| Early Funding | Dec 12, 2024 | ||||
| Seed | Nov 11, 2021 | ||||
| Grant | May 1, 2021 | ||||
Pre Seed | Oct 10, 2019 |
For institutional investors. Book with your work email.
BioSapien Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Golden Gate Ventures | Early Funding, VC Round |
| JPIN 1 | VC Round |
| Global Ventures | Early Funding, VC Round |
| Dara Holdings | Early Funding, VC Round |
| Side Door Ventures | Seed |
| Dara Management | Early Funding |
| Globivest | VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 138% MoM.
- Jul 2, 2026
Grew 30% QoQ from 10 to 13 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- increases_headcount_bySep 10, 2026
Biosapien increases headcount by 12 professionals across leadership and operational roles.
- recognized_asAug 14, 2026
The Galien Foundation nominates Biosapien as “Best Startup” in the 2026 Prix Galien USA Awards, with the San Diego-based biotech company shortlisted for its potential to improve human health on Aug 14th '26.
For institutional investors. Book with your work email.
BioSapien Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioSapien Inc.'s valuation, stock price, and market status.
Is BioSapien Inc. a public or private company?
BioSapien Inc. is a private company.
What is the current stock price of BioSapien Inc.?
BioSapien Inc. is a private company, so its shares have no public market price. Caplight tracks BioSapien Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioSapien Inc. worth (valuation)?
Valuation information for BioSapien Inc. is not publicly available.
Can I buy BioSapien Inc. stock?
BioSapien Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioSapien Inc.'s last funding round?
BioSapien Inc.'s most recent funding round was VC Round on July 7, 2025.
Who are the main investors in BioSapien Inc.?
Key investors in BioSapien Inc. include Global Ventures, Globivest, SOSV, Hikma Ventures.
Will BioSapien Inc. IPO soon?
No public IPO plans have been announced for BioSapien Inc..
How can I track BioSapien Inc. secondary market activity?
Caplight tracks bids, offers, and trades in BioSapien Inc.'s shares on secondary markets.